162 related articles for article (PubMed ID: 28506076)
1. NOS2 as an Emergent Player in Progression of Cancer.
Thomas DD; Wink DA
Antioxid Redox Signal; 2017 Jun; 26(17):963-965. PubMed ID: 28506076
[TBL] [Abstract][Full Text] [Related]
2. Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression.
Basudhar D; Somasundaram V; de Oliveira GA; Kesarwala A; Heinecke JL; Cheng RY; Glynn SA; Ambs S; Wink DA; Ridnour LA
Antioxid Redox Signal; 2017 Jun; 26(18):1044-1058. PubMed ID: 27464521
[TBL] [Abstract][Full Text] [Related]
3. Inflammation and Nitrosative Stress Effects in Ovarian and Prostate Pathology and Carcinogenesis.
Burke AJ; Garrido P; Johnson C; Sullivan FJ; Glynn SA
Antioxid Redox Signal; 2017 Jun; 26(18):1078-1090. PubMed ID: 28326819
[TBL] [Abstract][Full Text] [Related]
4. Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression.
Heinecke JL; Ridnour LA; Cheng RY; Switzer CH; Lizardo MM; Khanna C; Glynn SA; Hussain SP; Young HA; Ambs S; Wink DA
Proc Natl Acad Sci U S A; 2014 Apr; 111(17):6323-8. PubMed ID: 24733928
[TBL] [Abstract][Full Text] [Related]
5. Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer.
Switzer CH; Cheng RY; Ridnour LA; Glynn SA; Ambs S; Wink DA
Breast Cancer Res; 2012 Sep; 14(5):R125. PubMed ID: 22971289
[TBL] [Abstract][Full Text] [Related]
6. Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer.
Basudhar D; Glynn SA; Greer M; Somasundaram V; No JH; Scheiblin DA; Garrido P; Heinz WF; Ryan AE; Weiss JM; Cheng RYS; Ridnour LA; Lockett SJ; McVicar DW; Ambs S; Wink DA
Proc Natl Acad Sci U S A; 2017 Dec; 114(49):13030-13035. PubMed ID: 29087320
[TBL] [Abstract][Full Text] [Related]
7. Candidate pathways linking inducible nitric oxide synthase to a basal-like transcription pattern and tumor progression in human breast cancer.
Ambs S; Glynn SA
Cell Cycle; 2011 Feb; 10(4):619-24. PubMed ID: 21293193
[TBL] [Abstract][Full Text] [Related]
8. Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancer.
Wang J; He P; Gaida M; Yang S; Schetter AJ; Gaedcke J; Ghadimi BM; Ried T; Yfantis H; Lee D; Weiss JM; Stauffer J; Hanna N; Alexander HR; Hussain SP
Oncotarget; 2016 Aug; 7(33):52993-53004. PubMed ID: 27367029
[TBL] [Abstract][Full Text] [Related]
9. Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients.
Glynn SA; Boersma BJ; Dorsey TH; Yi M; Yfantis HG; Ridnour LA; Martin DN; Switzer CH; Hudson RS; Wink DA; Lee DH; Stephens RM; Ambs S
J Clin Invest; 2010 Nov; 120(11):3843-54. PubMed ID: 20978357
[TBL] [Abstract][Full Text] [Related]
10. Molecular Mechanisms of Nitric Oxide in Cancer Progression, Signal Transduction, and Metabolism.
Somasundaram V; Basudhar D; Bharadwaj G; No JH; Ridnour LA; Cheng RYS; Fujita M; Thomas DD; Anderson SK; McVicar DW; Wink DA
Antioxid Redox Signal; 2019 Mar; 30(8):1124-1143. PubMed ID: 29634348
[TBL] [Abstract][Full Text] [Related]
11. High nitric oxide production, secondary to inducible nitric oxide synthase expression, is essential for regulation of the tumour-initiating properties of colon cancer stem cells.
Puglisi MA; Cenciarelli C; Tesori V; Cappellari M; Martini M; Di Francesco AM; Giorda E; Carsetti R; Ricci-Vitiani L; Gasbarrini A
J Pathol; 2015 Aug; 236(4):479-90. PubMed ID: 25875314
[TBL] [Abstract][Full Text] [Related]
12. Assessing the predictive response of a simple and sensitive blood-based biomarker between estrogen-negative solid tumors.
Mohan S; Patel S; Barlow D; Rojas AC
Adv Med Sci; 2020 Sep; 65(2):424-428. PubMed ID: 32919119
[TBL] [Abstract][Full Text] [Related]
13. Inducible Nitric Oxide Synthase in the Carcinogenesis of Gastrointestinal Cancers.
de Oliveira GA; Cheng RYS; Ridnour LA; Basudhar D; Somasundaram V; McVicar DW; Monteiro HP; Wink DA
Antioxid Redox Signal; 2017 Jun; 26(18):1059-1077. PubMed ID: 27494631
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of the inducible nitric oxide synthase (NOS2) splicing variant S3 promotes autophagic cell death from nitrosative stress in SW480 human colon cancer cells.
Castro ED; Mathias PPM; Batista WL; Sato AYS; Toledo MS; de Almeida VT; Curcio MF; da Costa PE; Stern A; Monteiro HP
Cell Biol Int; 2022 Jan; 46(1):158-169. PubMed ID: 34719858
[TBL] [Abstract][Full Text] [Related]
15. Macrophage NOS2 in Tumor Leukocytes.
BrĂ¼ne B; Courtial N; Dehne N; Syed SN; Weigert A
Antioxid Redox Signal; 2017 Jun; 26(18):1023-1043. PubMed ID: 27397579
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic repression of PDZ-LIM domain-containing protein 2 promotes ovarian cancer via NOS2-derived nitric oxide signaling.
Zhao L; Yu C; Zhou S; Lau WB; Lau B; Luo Z; Lin Q; Yang H; Xuan Y; Yi T; Zhao X; Wei Y
Oncotarget; 2016 Jan; 7(2):1408-20. PubMed ID: 26593252
[TBL] [Abstract][Full Text] [Related]
17. NOS2 expression in glioma cell lines and glioma primary cell cultures: correlation with neurosphere generation and SOX-2 expression.
Palumbo P; Miconi G; Cinque B; Lombardi F; La Torre C; Dehcordi SR; Galzio R; Cimini A; Giordano A; Cifone MG
Oncotarget; 2017 Apr; 8(15):25582-25598. PubMed ID: 28424427
[TBL] [Abstract][Full Text] [Related]
18. NO
Wang J; Hussain SP
Antioxid Redox Signal; 2017 Jun; 26(17):1000-1008. PubMed ID: 27510096
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide synthase and breast cancer: role of TIMP-1 in NO-mediated Akt activation.
Ridnour LA; Barasch KM; Windhausen AN; Dorsey TH; Lizardo MM; Yfantis HG; Lee DH; Switzer CH; Cheng RY; Heinecke JL; Brueggemann E; Hines HB; Khanna C; Glynn SA; Ambs S; Wink DA
PLoS One; 2012; 7(9):e44081. PubMed ID: 22957045
[TBL] [Abstract][Full Text] [Related]
20. Involvement of NOS2 Activity on Human Glioma Cell Growth, Clonogenic Potential, and Neurosphere Generation.
Palumbo P; Lombardi F; Siragusa G; Dehcordi SR; Luzzi S; Cimini A; Cifone MG; Cinque B
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30227679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]